Australian pathologist and melanoma researcher Professor Richard Scolyer died in Sydney on 7 June 2026, aged 59.
He and Professor Georgina Long, co-medical directors of Melanoma Institute Australia, were jointly named 2024 Australian of the Year for transforming advanced-melanoma treatment with immunotherapy.
Diagnosed in June 2023 with grade 4 IDH-wildtype glioblastoma and given 6-8 months, he became the first patient of an experimental approach: combination immunotherapy before surgery plus a personalised vaccine.
Prime Minister Anthony Albanese offered a state funeral, which the family accepted; a trial based on his treatment is under way at Duke University, USA.
Born in Launceston, Tasmania
Diagnosed with grade 4 glioblastoma; given 6-8 months
Named Australian of the Year with Georgina Long
A$5.9 million pledged for a brain-cancer research chair in his name
Died in Sydney, aged 59
Immunotherapy drugs (checkpoint inhibitors) release the brakes on the immune system so it attacks cancer. Giving them before removing the tumour lets the immune system learn from the whole tumour first — the melanoma approach Scolyer applied to glioblastoma.
Simple Analogy: Showing the guard dog the burglar before the burglar is removed.
Research and treatment centre for melanoma; Scolyer and Long were its co-medical directors
General Awareness > Obituaries; Science > Diseases
The most common and aggressive malignant primary brain tumour in adults; WHO grade 4.
Skin cancer arising from melanocytes, the pigment-producing cells.